Neurology Devices are specialized surgical devices used for the treatment of disease or conditions of the Central Nervous System (CNS) and spine. Neurodiagnostic tests are used to diagnose suspected neurological disorders through Electroencephalographs (EEG), Electromyographs (EMG), or Magnetoencephalography (MEG) by looking at brain activity. GlobalData uses proprietary data and analytics to provide a comprehensive report on the electrical activity testing devices market, including market shares of different players within Taiwan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the electrical activity testing market in Taiwan was Natus Medical followed by Medtronic, OT Bioelettronica and Magstim.
Electroencephalograms are used to diagnose issues related to the electrical activity of the brain. Electromyograms are used to measure muscle activities and nerves in response to electrical activity. Magnetoencephalogram tests are the most advanced method of studying brain activity while actively functioning.
The value of the electrical activity testing devices market within Taiwan was expected to be over $10m in 2023.
For the latest complete market share analysis of electrical activity testing device market in Taiwan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
